Bruker Corporation (NASDAQ:BRKR) Analyst Rating Consensus

Bruker Corporation (NASDAQ:BRKR) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 2.25 by 12 Brokerage Firm. 5 Wall Street Firms have rated the stock as a strong buys. 6 Brokerage Firms have advised hold. A sell rating was given by 1 analyst.

Other Equity analysts have also commented on the company shares. BTIG Research downgrades its view on Bruker Corporation (NASDAQ:BRKR) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. Earlier, the shares had a rating of Buy. The rating by the firm was issued on May 5, 2016.

Bruker Corporation (NASDAQ:BRKR) shares are expected to touch $29 in the short term. This short term price target has been shared by 10 analysts. However, the standard deviation of short term price estimate has been valued at 2.91. The target price could hit $34 on the higher end and $25 on the lower end.

Bruker Corporation (NASDAQ:BRKR) witnessed a decline in the market cap on Tuesday as its shares dropped 1.44% or 0.35 points. After the session commenced at $24.39, the stock reached the higher end at $24.65 while it hit a low of $23.9. With the volume soaring to 848,962 shares, the last trade was called at $24.03. The company has a 52-week high of $29.85. The company has a market cap of $3,880 million and there are 161,454,760 shares in outstanding. The 52-week low of the share price is $15.778.

Shares of Bruker Corporation appreciated by 0.38% during the last five trading days but lost 8.04% on a 4-week basis. Bruker Corporation has dropped 13.02% during the last 3-month period . Year-to-Date the stock performance stands at -0.69%.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.